BioCentury
ARTICLE | Financial News

Trevi raises $50.5M in series C

July 21, 2017 8:34 PM UTC

On July 20, dermatology play Trevi Therapeutics Inc. (New Haven, Conn.) raised $50.5 million in a series C round led by New Enterprise Associates. New investors Lundbeckfonden Ventures, Omega Funds, and Aperture Venture Partners also participated, as did existing investor TPG Biotech...